Selskabets formål er forskning og udvikling af lægemidler og dermed beslægtet virksomhed.
| Year | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | -3.5 mio. | -3.9 mio. | 4.8 mio. | 4.6 mio. | 1 | |
CVR: 43770209
Erik Vinther joined the board
Peter Horn Møller left the board
Jan Stenvang joined as director
Erik Vinther left as director
Sønderup Godkendt Revisionsaktieselskab appointed as auditor
Sønderup I/S, statsautoriserede revisorer resigned as auditor
Marigold Maturation Fund K/S registered with 15% ownership
Peter Horn Møller joined the board
Søren Bregenholt Frederiksen joined the board
Peter Horn Møller left the board
Compared to 131 companies in Fremstilling af farmaceutiske præparater
Comparison is based on industry median values
Companies in the same industry and area
companydata.dk